Message-ID: <43FF488D.7000307@naggum.no>
From: Erik Naggum <erik@naggum.no>
Organization: Ungregarious News
User-Agent: Mozilla/5.0 (X11; U; Linux i686; en-US; rv:1.7.12) Gecko/20060205 Netscape/7.3
X-Accept-Language: en-us, en, nb, no, da, sv, de-de, de, fr-fr, fr
MIME-Version: 1.0
To: SKEPSIS:;
Subject: Re: Fredag
References: <BAY109-F19E883FB554934419A27BDB5F30@phx.gbl>
In-Reply-To: <BAY109-F19E883FB554934419A27BDB5F30@phx.gbl>
X-Enigmail-Version: 0.93.0.0
OpenPGP: id=C7F58576CC585167; url=http://erik.naggum.no/C7F58576CC585167.key
Content-Type: multipart/signed; protocol="application/x-pkcs7-signature"; micalg=sha1; boundary="------------ms020104000900010201030603"
X-Spam-Score: -1.1 (-)
Sender: diskusjon-admin@lists.skepsis.no
Errors-To: diskusjon-admin@lists.skepsis.no
X-BeenThere: diskusjon@lists.skepsis.no
X-Mailman-Version: 2.0.11
Precedence: bulk
List-Unsubscribe: <http://lists.skepsis.no/mailman/listinfo/diskusjon>,
	<mailto:diskusjon-request@lists.skepsis.no?subject=unsubscribe>
List-Id: Skepsis generelle diskusjonsliste <diskusjon.lists.skepsis.no>
List-Post: <mailto:diskusjon@lists.skepsis.no>
List-Help: <mailto:diskusjon-request@lists.skepsis.no?subject=help>
List-Subscribe: <http://lists.skepsis.no/mailman/listinfo/diskusjon>,
	<mailto:diskusjon-request@lists.skepsis.no?subject=subscribe>
List-Archive: <http://lists.skepsis.no/mailman/private/diskusjon/>
Date: Fri, 24 Feb 2006 17:55:25 +0000

This is a cryptographically signed message in MIME format.

--------------ms020104000900010201030603
Content-Type: text/plain; charset=ISO-8859-1; format=flowed
Content-Transfer-Encoding: 8bit

* Haldor Fosse @2006-02-24 13:58Z
> Hvor i all verden er sykehusene? hvorfor tar de ikke dette i bruk med en 
> gang????

Jeg tror det er fordi sykehusene og legene (nemlig de legene som tjener 
mer enn journalister), og legemiddelindustrien, nemlig det 
medisinindustrielle kompleks, med sitt veldige profittmotiv gjør folk så 
syke som mulig, men ikke sykere (dvs, døde), slik at de kan håve inn på 
å late som om de leger symptomer, mens de egentlig skuffer inn penger på 
virkningsløse stoffer og ikke-helbredende teknikker som bare får folk 
til å /føle/ seg bedre og som ... Hm, nei, vent, jeg tenker visst på 
noen andre.

Erik Naggum
-- 
Member of: AAAS ACM AMS APS ASA EMS IEEE IMS MAA NYAS NBF NFF NMF
What do I read?  See http://erik.naggum.no/sources-and-resources/
12 blasphemous Muhammad drawings scaled to match relevance ::::::
ID: 2006-055-64021    Nullius in verba.    Lectitare humanum est.

--------------ms020104000900010201030603
Content-Type: application/x-pkcs7-signature; name="smime.p7s"
Content-Transfer-Encoding: base64
Content-Disposition: attachment; filename="smime.p7s"
Content-Description: S/MIME Cryptographic Signature
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--------------ms020104000900010201030603--

_______________________________________________
diskusjon mailing list
diskusjon@lists.skepsis.no
http://lists.skepsis.no/mailman/listinfo/diskusjon
